We are live on
!
Find out more
Canada Life Portfolio holdings
AUM
$55.8B
1-Year Est. Return
26.04%
This Fund
S&P 500
This Quarter
Est. Return
+10.02%
1 Year Est. Return
+26.04%
3 Year Est. Return
+87.85%
5 Year Est. Return
+117.08%
10 Year Est. Return
+382.61%
AUM
$38B
AUM Growth
+$2.83B
(+8%)
Cap. Flow
-$66.8M
Cap. Flow
% of AUM
-0.18%
Top 10 Holdings %
Top 10 Hldgs %
19.42%
Holding
2,424
New
34
Increased
1,207
Reduced
842
Closed
77
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$58.2M |
| 2 |
Exelon
EXC
|
+$44.1M |
| 3 |
Prologis
PLD
|
+$37.8M |
| 4 |
Johnson & Johnson
JNJ
|
+$29.9M |
| 5 |
Cigna
CI
|
+$28.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$63.9M |
| 2 |
Allstate
ALL
|
+$39.3M |
| 3 |
Gilead Sciences
GILD
|
+$31.8M |
| 4 |
Enbridge
ENB
|
+$30.1M |
| 5 |
Oracle
ORCL
|
+$29.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.67% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 13.83% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Industrials | 7.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DOOR
2001
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $93K | ﹤0.01% |
1,148
| – | – |
|
2002
Ginkgo Bioworks
DNA
$500M
| $92K | ﹤0.01% |
1,352
+587
| +77% | +$54K |
|
2003
Horizon Bancorp
HBNC
$1.03B
| $92K | ﹤0.01% |
6,040
+2,035
| +51% | +$33.6K |
|
2004
Parsons
PSN
$4.93B
| $92K | ﹤0.01% |
1,967
| – | – |
|
2005
Twist Bioscience
TWST
$7.83B
| $92K | ﹤0.01% |
3,867
+848
| +28% | +$24.6K |
|
|
ONT
2006
Onterris Inc
ONT
$546M
| $91K | ﹤0.01% |
2,047
+476
| +30% | +$20.1K |
|
|
HEES
2007
DELISTED
H&E Equipment Services
HEES
| $90K | ﹤0.01% |
1,966
| – | – |
|
2008
Kearny Financial
KRNY
$595M
| $90K | ﹤0.01% |
8,793
+2,961
| +51% | +$29.7K |
|
2009
IAMGOLD
IAG
$10.5B
| $88K | ﹤0.01% |
34,544
+13,080
| +61% | +$22.7K |
|
|
SFIX
2010
Stitch Fix
SFIX
$530M
| $86K | ﹤0.01% |
27,580
+14,233
| +107% | +$53.2K |
|
|
EVOP
2011
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $85K | ﹤0.01% |
2,488
| – | – |
|
2012
Camden National
CAC
$970M
| $83K | ﹤0.01% |
1,979
+498
| +34% | +$21.2K |
|
|
AKRO
2013
DELISTED
Akero Therapeutics
AKRO
| $82K | ﹤0.01% |
1,486
+901
| +154% | +$38.6K |
|
2014
Krystal Biotech
KRYS
$9.81B
| $81K | ﹤0.01% |
1,013
| – | – |
|
2015
NovaGold Resources
NG
$3.35B
| $81K | ﹤0.01% |
13,561
| – | – |
|
2016
PJT Partners
PJT
$4.33B
| $81K | ﹤0.01% |
1,094
| – | – |
|
2017
Ennis
EBF
$558M
| $80K | ﹤0.01% |
3,616
+760
| +27% | +$16.9K |
|
2018
Revolution Medicines
RVMD
$44.4B
| $80K | ﹤0.01% |
3,356
+830
| +33% | +$17.6K |
|
2019
BioNTech
BNTX
$23.3B
| $79K | ﹤0.01% |
524
+60
| +13% | +$9.23K |
|
2020
TG Therapeutics
TGTX
$7.52B
| $79K | ﹤0.01% |
6,682
| – | – |
|
|
FFIC
2021
DELISTED
Flushing Financial
FFIC
| $78K | ﹤0.01% |
4,000
+1,340
| +50% | +$27K |
|
|
RVNC
2022
DELISTED
Revance Therapeutics, Inc.
RVNC
| $78K | ﹤0.01% |
4,196
+874
| +26% | +$20K |
|
|
TUP
2023
DELISTED
Tupperware Brands Corporation
TUP
| $78K | ﹤0.01% |
18,809
-30,151
| -62% | -$162K |
|
2024
Tilray
TLRY
$602M
| $77K | ﹤0.01% |
2,829
+462
| +20% | +$16.2K |
|
2025
Midland States Bancorp
MSBI
$689M
| $75K | ﹤0.01% |
2,812
+770
| +38% | +$20.4K |
|
Similar funds
Canada Life's Q4 2022 Portfolio in Review
As of Q4 2022, Canada Life held 2,424 positions worth $38B, up 8% from $35.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2022: portfolio turnover was 4.6%. Canada Life opened 34 new positions and exited 77, leaving the 2,424-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Canada Life's largest Q4 2022 buy was Stellantis: 4,179,449 shares worth $59.5M.
- Canada Life added most to Exelon in Q4 2022, an estimated $44.1M increase.
- Canada Life's biggest Q4 2022 reduction was Texas Instruments, cutting an estimated $63.9M.
- Canada Life fully exited Brookfield in Q4 2022, selling an estimated $27.1M.
- Canada Life's ten largest holdings make up 19% of its $38B portfolio in Q4 2022.
- Canada Life opened 34 new positions and closed 77 in Q4 2022.
- Canada Life's portfolio value rose 8% quarter-over-quarter to $38B.
Based on Canada Life's 13F filing for Q4 2022, filed 10 Feb 2023.